Based on your clinical or research question, we will assess the available data and develop a suitable meta-analysis approach to answer the question. We will consider the nature of the available data (continuous or binary; individual patient or aggregate data; heterogeneity; quality and risk of bias), which model (fixed effects or random effects) to apply, and what effect sizes (risk ratios and odds ratios) to consider. Presentation of results will also be considered.
- Increasingly important for treatment decisions
- Be the first to shine a new light on a current treatment
Ready for you in 10 days.
Meet some of the Edanz team that will manage your projects:
Daniel McGowan, PhD, CMPP
Chief Science Officer
Daniel has a research background in molecular biology (Auckland University, Cambridge University, Babraham Institute) where he specialized in Huntington's disease. Following a successful research career, he was on the editorial team of Nature Reviews Neuroscience. He has been Edanz Science Director since 2008, and chairs the Edanz Science Advisory Committee.
James Graham Phd CMPP
James holds a PhD in Biochemistry and has a research background in prions and Parkinson's disease (The Roslin Institute and DZNE Bonn). As Edanz' Science Director, he oversees our team to help researchers develop innovative ideas and plan, design, run, and execute both clinical and non-clinical studies. In addition, James is a certified medical publications professional with substantial experience in the peer-review process.
Ayli Chong, ELS, CMPP
Researcher Services Manager
Ayli is a graduate of The University of Sydney, trained in assessing and treating individuals with impairments in hearing, speech, language, voice, and swallowing. She boasts over 10 years of experience in scientific communication and publishing and is a certified medical publications professional. Ayli is the Researcher Services Manager at Edanz, overseeing a portfolio of services and customized projects aimed at extending the reach of researchers' results in the fast-changing scientific communication landscape.
About Springer Nature and Edanz:
Springer Nature and Edanz are independent of each other, but Springer Nature is providing Edanz services on this platform because we believe they are valuable and useful for our customers. Edanz is a trustworthy provider who we have collaborated with for many years.
Springer Nature advances discovery by publishing robust and insightful research, supporting the development of new areas of knowledge and making ideas and information accessible around the world. We provide the best possible service to the whole research community.
Edanz (www.edanz.com) is a scientific research support service committed to providing innovative solutions to the challenges faced by the international research community, from individual researchers and clinicians to large institutions. Edanz helps scientists reach their goals by providing guidance and support at every stage of research planning, execution, writing, and publication processes. Our team includes researchers, clinicians, journal editors, peer reviewers, publication consultants, medical writers and medical communications specialists. Edanz is part of M3 Group (corporate.m3.com), and a sister company to Doctors.net.uk, Medlive (medlive.cn), m3.com and MDLinx.